↓ Skip to main content

Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015
Altmetric Badge

Mentioned by

twitter
2 X users

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer
Published in
Journal for Immunotherapy of Cancer, November 2015
DOI 10.1186/2051-1426-3-s2-p102
Authors

Nitya Nair, Ed Lemmens, Amanda Enstrom, Shih-Yu Chen, Serena Chang, Dung Le, Elizabeth M Jaffee, Holden Maecker, Aimee L Murphy, Dirk G Brockstedt, Chan Whiting

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 27%
Lecturer > Senior Lecturer 1 9%
Student > Ph. D. Student 1 9%
Student > Bachelor 1 9%
Student > Master 1 9%
Other 1 9%
Unknown 3 27%
Readers by discipline Count As %
Medicine and Dentistry 4 36%
Immunology and Microbiology 1 9%
Biochemistry, Genetics and Molecular Biology 1 9%
Neuroscience 1 9%
Engineering 1 9%
Other 0 0%
Unknown 3 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 November 2015.
All research outputs
#20,089,475
of 25,559,053 outputs
Outputs from Journal for Immunotherapy of Cancer
#3,045
of 3,459 outputs
Outputs of similar age
#203,579
of 297,233 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#88
of 97 outputs
Altmetric has tracked 25,559,053 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,459 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one is in the 9th percentile – i.e., 9% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 297,233 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.